Purchase Order 75F40122P00438
Award Date 9/6/22
Potential Completion Date 9/29/25
Potential Value $130K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' Food and Drug Administration awarded a $43,243.20 firm fixed price purchase order to Certara USA Inc. for SEND EXPLORER licenses. The place of performance is Silver Spring, Maryland. The one-year contract runs from September 12, 2023 through September 14, 2024. Certara USA Inc. will provide the FDA with software licenses to support the agency's regulatory science and public health protection missions. No subcontractors or set asides were identified....
- This is a $91,396 firm fixed-price purchase order issued by the Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (De), for the ratification of Phoenix Quantum licenses in fiscal year 2017. Certara is a technology-enabled drug development and drug safety consultancy that specializes in biosimulation and has received multiple federal contracts from the Department of Health and Human Services, including the FDA, National Institutes of Health, and Centers for...
- This is a $169,504.71 firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), a technology-enabled drug development and drug safety consultancy. The contract provides annual named user server licenses for Certara's Phoenix WinNonlin, Phoenix Connect, Phoenix NLME software, as well as an unlimited server license for distributed computing. This supports the FDA's...
- The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Certara UK LIMITED (doing business as Certara) on September 6, 2023, for SIMCYP software licenses with a ceiling value of $815,948. The contract will be performed in Great Britain, United Kingdom, and is scheduled for ultimate completion by September 20, 2028. No set-aside designation was applied to this award. Certara provides physiologically-based pharmacokinetic (PBPK) modeling software that simulates drug...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Certara USA Inc., a leading provider of biosimulation software and consulting services. The contract, valued at $16,441.10, is for the procurement of software licenses for Certara's proprietary modeling and simulation tools, including Phoenix WinNonlin, Certara Phoenix, CHEMOFFICE, and SEND EXPLORER. These software products enable federal scientists and reviewers to conduct...
- The U.S. Food and Drug Administration (FDA) awarded a $144,000.00 firm-fixed-price purchase order contract to Certara UK LIMITED, doing business as Certara, for the purchase of SIMCYP software. SIMCYP is a physiologically-based pharmacokinetic (PBPK) modeling software used to simulate drug absorption, distribution, metabolism, and excretion processes, which is crucial for optimizing drug development and facilitating regulatory reviews. This contract is not set aside for any specific business...
- The Food and Drug Administration (FDA) awarded a $65,451.84 firm fixed-price purchase order to Certara USA Inc. (doing business as Tripos (De)) for Phoenix Quantum licenses and support services. The contract was awarded on July 11, 2019, with an ultimate completion date of July 11, 2024, and was performed in Princeton, New Jersey. This contract reflects the FDA's ongoing reliance on Certara's pharmacokinetic and pharmacodynamic modeling software to support regulatory review activities and drug...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Pharsight Corporation, a subsidiary of Certara USA Inc. The contract, valued at $153,470.00, is for the provision of the "PHOENIX QUANTUM SOFTWARE BUNDLE" and is a total small business set-aside. The contract has a completion date of July 21, 2017. Certara USA Inc. is a leading global technology-enabled drug development and drug safety consultancy, specializing in biosimulation...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for the renewal of ADMET Predictor software licenses and associated support services. The contract, valued at $100,337.38, has an ultimate completion date of February 19, 2026. The original solicitation sought to renew the FDA's existing licenses for the ADMET Predictor software, which is used by the Center for Tobacco Products (CTP) for toxicology data mining and assessing the...